Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 7/20 | 0.51 |
| ▸ | SLC6A4 | P31645 | 6/20 | 0.51 |
| ▸ | SLC6A3 | Q01959 | 6/20 | 0.51 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.51 |
| ▸ | HTR2C | P28335 | 3/20 | 0.38 |
| ▸ | HTR2B | P41595 | 3/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.37 |
| ▸ | ABL1 | P00519 | 1/20 | 0.36 |
| ▸ | HTR1A | P08908 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | BCL9 | O00512 | 3/20 | 0.34 |
| ▸ | CTNNB1 | P35222 | 3/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4124141 | 1.00 | SLC6A2 (0.51) | SLC6A2SLC6A4SLC6A3KCNH2HTR2C | |
| SCHEMBL4126641 | 0.88 | SLC6A2 (0.55) | SLC6A2SLC6A4SLC6A3KCNH2HTR2C | |
| SCHEMBL4126638 | 0.88 | SLC6A2 (0.55) | SLC6A2SLC6A4SLC6A3KCNH2HTR2C | |
| SCHEMBL4144965 | 0.86 | SLC6A2 (0.53) | SLC6A2SLC6A4SLC6A3KCNH2HTR2C | |
| SCHEMBL4144969 | 0.86 | SLC6A2 (0.53) | SLC6A2SLC6A4SLC6A3KCNH2HTR2C | |
| SCHEMBL4125233 | 0.85 | SLC6A2 (0.47) | SLC6A2SLC6A4SLC6A3KCNH2HTR2C | |
| SCHEMBL4125229 | 0.85 | SLC6A2 (0.47) | SLC6A2SLC6A4SLC6A3KCNH2HTR2C | |
| SCHEMBL4137443 | 0.84 | KCNH2 (0.51) | SLC6A2SLC6A4SLC6A3KCNH2HTR2C | |
| SCHEMBL4137451 | 0.84 | KCNH2 (0.51) | SLC6A2SLC6A4SLC6A3KCNH2HTR2C | |
| SCHEMBL4137448 | 0.84 | KCNH2 (0.53) | SLC6A2SLC6A4SLC6A3KCNH2HTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090215857-A1 | Therapeutic Pyrrolidines | PFIZER PRODUCTS INC. (US) | 2009-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090215857-A1 | Therapeutic Pyrrolidines | OPRL1, HTR5A, OPRD1 | SLC6A2 28/4885SLC6A4 18/4885SLC6A3 19/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.